EP Patent

EP1655284A1 — 2-Phenylsulfopyrroles

Assigned to Aponetics AG · Expires 2006-05-10 · 20y expired

What this patent protects

The invention relates to novel 2-phenylsulfopyrroles of formula (I) wherein R 1 represents lower alkyl, halo-lower alkyl, cycloalkyl, hydroxy, lower alkoxy, halo-lower alkoxy, cycloalkoxy or cyano, R 2 represents hydrogen, halogen, lower alkyl, hydroxy or lower alkoxy, or…

USPTO Abstract

The invention relates to novel 2-phenylsulfopyrroles of formula (I) wherein R 1 represents lower alkyl, halo-lower alkyl, cycloalkyl, hydroxy, lower alkoxy, halo-lower alkoxy, cycloalkoxy or cyano, R 2 represents hydrogen, halogen, lower alkyl, hydroxy or lower alkoxy, or R 1 and R 2 together with the carbon atoms they are bound to form a ring, R 3 represents hydrogen, lower alkyl, lower alkoxy-lower alkyl or halo-lower alkyl, R 4 represents hydrogen, lower alkyl, a carbamoyl group C(O)NHR 8 , a sulfamoyl group SO 2 NHR 8 , halogen or cyano, and the other substituents have the meaning described in the specification; processes for the preparation thereof, pharmaceutical compositions containing same, the use thereof optionally in combination with one or more other pharmaceutically active compounds for the therapy of neoplastic diseases and autoimmune diseases, and a method for the treatment of such a diseases.

Drugs covered by this patent

Patent Metadata

Patent number
EP1655284A1
Jurisdiction
EP
Classification
Expires
2006-05-10
Drug substance claim
No
Drug product claim
No
Assignee
Aponetics AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.